Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
Clinical trial NCT01649466 · COMPLETED
Trial details
- NCT number
- NCT01649466
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-10-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.